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Dear Members of the New York Medical College (NYMC) Community,
I am pleased to share with you the August issue of the research newsletter that highlights
important research taking place at NYMC School of Medicine (SOM), including several COVID-19
related studies conducted by both faculty and students.
I am excited that our meaningful research here at NYMC and its clinical affiliates is being
recognized, as demonstrated by the recent selection of the NYMC Genomics Core Laboratory
by New York State as one of just five institutions to bolster state efforts in identifying COVID-19
variants.
We also partnered with Regeneron Pharmaceuticals on a high impact study published in Science
that used cutting edge technology to pinpoint a gene mutation that may protect against obesity.
You can read more about this important work done by researchers in the labs of Michal L. Schwartzman, Ph.D., professor
and chair of the Department of Pharmacology, and Victor Garcia, Ph.D. ’15, assistant professor of pharmacology, later in this
newsletter.
Congratulations to all faculty and students on their recent accomplishments, only a small portion of which are reported here. I am
confident much more progress lies ahead for the NYMC research community. I also want to especially thank the faculty and staff
mentors for helping our students carry out their summer research projects. Be safe and well.

Jerry L. Nadler, M.D., MACP, FAHA, FACE
Dean of the School of Medicine				
Professor of Medicine and Pharmacology
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NYMC Researchers Partner with Regeneron to Discover GPR75 Gene Mutations
that Protect Against Obesity
Researchers from NYMC and Regeneron Genetics Center (RGC) have
discovered rare genetic mutations in the GPR75 gene associated with
protection against obesity. As reported in Science, almost 650,000 people
were sequenced to find rare individuals with this genetic ‘superpower,’
providing new insights into the genetic basis of obesity. It is estimated that
more than one billion people could be suffering from obesity (body mass
index [BMI] of 30 or higher) by 2030.
NYMC researchers in the labs of Michal L. Schwartzman, Ph.D., professor
and chair of the Department of Pharmacology, and Victor Garcia, Ph.D. ’15,
assistant professor of pharmacology, in collaboration with RGC scientists
found that individuals who have at least one inactive copy of the GPR75 gene (L to R) Sakib Hossain, Michal Schwartzman, Ph.D.
Victor Garcia, Ph.D., and Jonathan Pascale
have lower BMI and, on average, tend to weigh about 12 pounds less and
face a 54 percent lower risk of obesity than those without the mutation. Protective ‘loss of function’ mutations were found in about
one of every 3,000 people sequenced.
Previous to this study, Dr. Garcia, while still an NYMC graduate student under Dr. Schwartzman’s mentorship, found the orphaned
G-protein coupled receptor, GPR75, to be the cellular target for the vasoactive and pro-inflammatory lipid 20-HETE (Circulation
Research 2017). In a subsequent 2021 study published in the British Journal of Pharmacology, the molecular underpinnings
of GPR75, were further characterized by Dr. Garcia’s lab, with relatively low levels of 20-HETE found to trigger a physiological
response in GPR75.
“In our preliminary studies, we identified protection from diet-driven obesity and associated metabolic and cardiovascular
complications in GPR75 knockout mice,” said Dr. Schwartzman. “This remarkable observation mirrored previous findings that
identified an association between high-fat, diet-induced obesity in animal models and BMI in humans and 20-HETE levels,
implicating 20-HETE as a key mediator driving weight gain and a diabetic phenotype (hyperglycemia and insulin resistance) in
mice.” Read full story about research on GPR75 gene.

NYMC Selected to Assist New York State in Identification of COVID-19 Variants
After a competitive request for proposal process, NYMC is among five institutions
selected by New York State to bolster state efforts in identifying COVID-19 variants.
The New York State Department of Health is partnering with the NYMC Genomics
Core Laboratory to access and process positive specimens of SARS-CoV-2, the
virus that causes COVID-19, from large multi-county areas in New York State
outside of New York City.
The NYMC Genomics Core Laboratory in the Department of Pathology,
Microbiology and Immunology, was established to house both basic and
translational genomics research, provide state-of-the-art next-generation
sequencing (NGS) technologies, conduct genomics experiments and bioinformatics
analyses, as well as provide opportunities for education and training in genomics
Weihua Huang, Ph.D.
and bioinformatics. The lab is directed by Weihua Huang, Ph.D., associate
professor of pathology, microbiology and immunology.
Data will be used to help build an understanding of disease manifestations, therapy or vaccine evasion and efficacy, and will
support other discoveries to inform public health intervention. Sequencing results from the partner laboratories will be reported to
the New York State Department of Health and the Global Initiative on Sharing Avian Influenza Data. NYMC expects to collaborate
with the Westchester Medical Center (WMC) Health Network to acquire samples from the Hudson Valley.
“I am elated at the selection of the Genomics Core Laboratory for this partnership, which not only affirms that NYMC and Touro
College and University System (TCUS) are at the forefront of COVID-19 research but allows us to play an important role in keeping
the public safe,” said Salomon Amar, D.D.S., Ph.D., vice president for research at NYMC, and senior vice president for research
affairs at TCUS, who is the principal investigator on the project.
“This selection is a testament to the outstanding research work done under the directorship of Dr. Huang and I feel honored to be
part of this team. Thanks to everyone involved in this invaluable work, including NYMC leadership and our clinical affiliate WMC
Health Network, this study will allow us to better track, monitor and combat this unprecedented pandemic of COVID-19,” said
Humayun Islam, M.D., Ph.D., chair of the Department of Pathology, Microbiology and Immunology. Read full story on the NYMC
Genomics Core Laboratory selection.

Research Finds COVID-19 Patients at Higher Risk for Cerebral Venous
Thrombosis
New research by NYMC faculty and staff found that cerebral venous thrombosis
(CVT) occurs at a higher frequency in COVID-19 patients and that it predominantly
affects patients who are young, male and otherwise healthy. Findings from the
study, which examined case records of 13,500 patients with COVID-19 admitted
to six New York metropolitan tertiary care centers in the first half of 2020, were
recently published in the American Journal of Neuroradiology.
The study, Cerebral Venous Thrombosis in COVID-19: A New York Metropolitan
Cohort Study, was led by Fawaz Al-Mufti, M.D., assistant professor of neurology,
neurosurgery and of radiology, and Chirag Gandhi, M.D., chair of the Department
of Neurosurgery and professor of neurosurgery, neurology and of radiology.
Additional authors on the study, include Ramandeep Sahni, M.D., clinical
associate professor of neurology; Jonathan Ogulnick, SOM Class of 2022; Philip
J. Overby, M.D., clinical associate professor of pediatrics and of neurology; Jared Cooper, M.D., neuro-interventional surgery
fellow; Jose Dominguez, M.D., neurosurgery resident; Tolga Sursal, M.D., neurosurgery resident; Haris Kamal, M.D., neurointerventional surgery fellow; Katarina Dakay, M.D., neuro-interventional surgery fellow; and Edwin Gulko, M.D., assistant
professor of radiology.
The group embarked on the study after physicians at Westchester Medical Center (WMC), a major academic affiliate of
NYMC, observed an increased incidence of CVT, a rare type of stroke in which a clot forms in the veins of the brain instead
of an artery, in patients infected with COVID-19. Dr. Al-Mufti, who is the associate chair for research in the Department of
Neurology and an interventional neurologist/neurointensivist at WMC, subsequently collected data on COVID-19 patients who
also had CVT from across the New York greater metropolitan area. Read full story on study on cerebral venous thrombosis.

NYMC Student Examines Early Predictors of Severe Disease Progression for
COVID-19 Patients
While much of clinical COVID-19 research has focused on treatment for the sickest patients
in hospital intensive care units, many of those same patients first present to clinics with
milder symptoms. In a recently published study in the Journal of Clinical Medicine, Aaron
Rips, SOM Class of 2023, examined the most common early prognostic indicators in
patients presenting with mild cases of COVID-19 in the outpatient/ambulatory setting that
indicated later progression to severe disease and subsequent hospitalization. His findings
suggest the presence of comorbidities, shortness of breath and lymphopenia as the most
reliable predictors of adverse outcomes, with 100 percent of those with more than three
comorbidities requiring hospitalization.
“Often patients go to their physicians or a clinic with any number of symptoms such as
cough, fever or shortness of breath, and are then sent home as their symptoms do not
require emergency care,” said Mr. Rips, who worked on the research with a team of clinicians
Aaron Rips, SOM Class of 2023
at Benaroya Research Institute in Seattle, Washington, in partnership with Virginia Mason
Hospital. “The majority of these patients go on to recover at home from COVID-19 with no further complications. A smaller
subset of these patients returns to the clinic or hospital several days later with severe symptoms and subsequently requires
hospitalization, ventilators and intensive treatment.”
“If doctors and clinicians can identify which patients are at high risk for serious complications before such complications occur,
early intervention and treatment can help save both lives and resources. Preventative medicine has become increasingly
important in medical practice and our research ties into this philosophy,” he said. Read full story on study of early predictors
for severe disease progression.

NYMC Faculty Demonstrate Safety of Organ Transplantation in Recovered
COVID-19 Patients
Challenges in organ transplantation regarding the safety of transplanting organs to a patient recovered from COVID-19 as
well as from a donor with COVID-19 were addressed by NYMC faculty recently, with their successful findings published in
the journals Transplant Infectious Diseases and American Journal of Transplantation. Several NYMC faculty contributed
to the reports, with Abhay Dhand, M.D., associate professor of medicine and director of transplant infectious diseases at
Westchester Medical Center, a major academic affiliate, serving as both reports’ lead author.
“Transplanting organs in recently recovered COVID-19 patients can be challenging, and this was especially true during the
earlier days of the pandemic, as we struggled to learn more about the virus and its resulting complications,” said Dr. Dhand.
“In the end, we concluded that prospective liver recipients can and should be considered for transplantation after recovering
from COVID-19, as long as the proper evaluation, donor selection and risk-benefit analysis is performed.”
Additional NYMC faculty who contributed to the reports included: Roxana Bodin, M.D., assistant professor of medicine;
Thomas Diflo, M.D., professor of surgery; Alan Gass, M.D., professor of medicine; Masashi Kai, M.D., assistant professor of
surgery; Rifat Latifi, M.D., the Felicien M. Steichen, M.D., Professor and Chair of Surgery; Edward Lebovics, M.D., the Sarah
C. Upham Professor of Gastroenterology and professor of medicine; Christopher Nabors, M.D., Ph.D., assistant professor of
medicine; Seigo Nishida, M.D., clinical professor of surgery; Rajat Nog, M.D., assistant professor of medicine; Suguru Ohira,
M.D., Ph.D., clinical assistant professor of surgery; Hiroshi Sogawa, M.D., associate professor of surgery; David Spielvogel,
M.D., associate professor of surgery; and David C. Wolf, M.D., professor of medicine.

Grants Corner
Fawaz Al-Mufti, M.D., assistant professor of neurology, neurosurgery and of radiology, received a $144,056 grant from
NovaSignal Corp. for “A Prospective Non-Invasive Study of Cerebral Blood Flow Velocity Morphology for Quantification of
Intracranial Pressure.”
Ama Buskwofie, M.D., assistant professor of obstetrics and gynecology, received a $62,445 grant from Vascular Biogenics/
GOG Foundation for “The OVAL Study: A Randomized, Controlled, Double-Arm, Double Blind, Multi-Center Study of
Ofranergene Obadenovec (VB-111) Combined with Paclitaxel vs. Paclitaxel Combined with Placebo for the Treatment of
Recurrent Platinum-Resistant Ovarian Cancer.”
Tetyana Cheairs, M.D., M.S.P.H., assistant professor of pathology, microbiology and immunology, received a $45,000 grant
from Firmenich for “Detection of Thresholds for DNA Adduct Formation by Alkylbenzenes in the Turkey Egg Genotoxicity
Assay.”
Savneek Chugh, M.D., associate professor of medicine, received a $39,000 grant from Alexicon Pharmaceuticals for “A Phase
3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab
Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory
Distress Syndrome” and a grant for $26,000 from Retrophin for “A Randomized Multi center, Double-Blinded, Parallel, ActiveControl Study of the Effects of Sparsentan, a Dual Endothelin Receptor and Angiotensin Receptor Blocker, on Renal Outcomes
in Patients with Primary Focal Segmental Glomerulosclerosis (FSGS).”
Marina K. Holz, Ph.D., dean of the Graduate School of Basic and Medical Sciences and professor of cell biology and
anatomy, received a $123,000 grant from the U.S. Army for “Characterization of Estrogen-mTORC1 Signaling Network in TSC/
LAM.”
Marc El Khoury, M.D., associate professor of medicine, received a $66,403 grant from ContraFect for “A Randomized,
Double-Blind Placebo-Controlled Study of the Efficacy and Safety of a Single Dose of Exebacase in Adult Patients Receiving
Standard-of-Care Antibiotic for the Treatment of Staphylococcus aureus bloodstream Infections (Bacteremia).”
Srihari Naidu, M.D., professor of medicine, received a $174,666 grant from Myokardia for “A Randomized, Double-Blind,
Placebo-Controlled Study to Evaluate Mavacamten in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy who
are Eligible for Septal Reduction Therapy.”
Steven Wolf, M.D., clinical professor of pediatrics, received a $22,340 grant from Zogenix for “An Open-Label Extension Trial
to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy for Seizures
4
in Patients with Rare Seizure Disorders Such as Epileptic Encephalopathies Including Dravet Syndrome and Lennox-Gastaut
Syndrome.”

Department of Surgery Hosts 18th Annual Louis R.M. DelGuercio
Distinguished Visiting Professorship and Research Day
The 18th Annual Louis R.M. DelGuercio Distinguished Visiting
Professorship and Research Day, featuring keynote speaker Raymond
R. Price, M.D., FACS, was held at NYMC on June 18. During his
address, Dr. Price, vice chair for global health at the Center for Global
Surgery, clinical professor and adjunct associate professor of the
Department of Family and Preventive Medicine Division of Public
Health at the University of Utah, shared an inspirational story of his
experience with global health and the immense impact it has on
communities worldwide.
The Louis R.M. DelGuercio Research Day, sponsored annually since
L to R, Roberto Bergamaschi, M.D., Ph.D., Maria Cast2002 by the Department of Surgery, provides students, residents
aldi, M.D., Thomas Diflo, M.D., Raymond Price, M.D.,
Matthew McGuirk, Klaudia Koziol and Rifat Latifi, M.D.
and fellows, with both an opportunity to showcase their research
and an occasion to network, learn from one another and potentially combine efforts to promote the advancement of surgical
research. During the event, John A. Savino, M.D., former chair and director of surgery, reviewed the life and scientific impact
of Professor emeritus Louis R.M. Del Guercio, M.D., who served as chair of the Department of Surgery for 24 years before
retiring in 2000.
This year, the Department received 70 submissions from students, residents and fellows. Rifat Latifi, M.D., FACS, FICS,
FKCS, the Felicien M. Steichen, M.D., Professor and Chair of Surgery, remarked, “This year we were honored by having Dr.
Price as the distinguished professor, who is clearly one of the most prominent surgeons working globally, and whose work has
improved the lives of people in many countries. Moreover, the quality of submissions was excellent and most of these papers
could have been presented in any national or international meeting.” View list of award winners and video of event.

Research on Structural Heart Disease Presented by NYMC Students at
American College of Cardiology Conference
NYMC students—Akiva Rosenzveig and Joshua Hsu, both in the SOM Class of 2023—were chosen
to present their research into transcatheter aortic valve replacement (TAVR) and geometric changes
in heart structure at the American College of Cardiology annual conference.

Akiva Rosenzveig

Joshua Hsu

TAVR, a minimally invasive procedure that accesses the heart by way of catheters to insert a
prosthetic valve, has become a feasible alternative to open heart aortic valve surgery for individuals
with aortic stenosis. Originally intended as an alternative for only patients who face prohibitive risk
with surgery, TAVR is now approved by the FDA for patients who have a low risk surgical profile.
Under the mentorship of Hasan Ahmad, M.D., clinical associate professor of medicine, and Syed
Zaid, M.D., cardiology fellow, Mr. Rosenzveig and Mr. Hsu, joined by Medha Biswas, M.D. ’20,
examined the potential impact of TAVR on patients who needed both an aortic valve and mitral valve
replacement, with particular emphasis on changes to the heart structures related to the left ventricular
outflow tract and the mitral annulus.
“As there has been a precipitous rise in the use of TAVR for aortic stenosis treatment, our goal was
to look at the impact the new aortic valve has on the heart anatomy,” said Mr. Rosenzveig. “Sixteen
percent of patients undergoing TAVR have concomitant mitral regurgitation, some of which requires
transcatheter mitral valve replacement (TMVR). The mitral valve apparatus is very closely behind
the aortic valve apparatus, specifically the outflow tract that leads from the left ventricle to the aortic
valve. TMVR involves placing a new valve that pushes the original leaflets out (as opposed to
removing them as one would do surgically), allowing for the anterior mitral leaflet to obstruct the left
ventricular outflow tract (LVOT). Our objective was to assess the effect TAVR has on the LVOT size
and the geometrical relationship between the mitral and aortic valvular apparatuses.”

“We found that TAVR does not meaningfully affect the geometric relationship between the mitral and aortic valvular
apparatuses, but it does increase the LVOT area,” said Mr. Rosenzveig. “The increase in LVOT area without a change in
aorto-mitral geometry suggests a possible reduction in risk of LVOT obstruction following a TMVR procedure.” Read full story
on TAVR research.

NYMC Students Examine Success of Sexual Health Education Lecture Series
Illustrating how student-initiated research projects can both lead to publication and inform ongoing curriculum changes, a
group of NYMC students investigated the success of the student-driven sexual health education lecture series with their study
recently accepted for publication in the Journal of Advances in Medical Education and Professionalism. Hosted by several
NYMC interest groups, including American Medical Women Association, LGBTQ Advocacy in Medicine, the OB-GYN Interest
Group, the Psychiatry Interest Group, the Infectious Disease Interest Group, Physicians for Human Rights and Medical
Students for Choice, the lecture series, which was attended by over 250 medical students, featured content area experts on a
variety of topics ranging from caring for adolescent LGBTQ patients to working with victims of domestic violence and human
trafficking.
Under the mentorship of Jennifer Koestler, M.D., senior associate dean for medical education, and Donald Risucci, Ph.D.,
assistant dean of assessment and evaluation, SOM students Kayla Morel, Class of 2022, and Class of 2023 classmates
Camille Briskin and Madison Kasoff, together with Sarah Speigel, M.D. ’20; Jasmin Mahabamunuge, M.D. ’21; John Budrow,
M.D. ’21; Innes Tounkel, M.D. ’21; and Cassidy Hart, M.D. ’21, evaluated the effectiveness of the lecture series to improve
medical student comfort with diverse sexual health content.
“National surveys of medical students reveal students perceive that they receive insufficient training on gender and sexual
health topics in medical school,” said Ms. Morel. “The health disparities disproportionately affecting gender and sexual
minorities compared to heterosexual and cis-gender individuals are well studied with emerging research finding that provider
bias and inadequate training contribute to these disparities.”
After comparing pre- and post-lecture series survey responses, investigators found that students had significantly greater
comfort discussing topics around sexual health with adult, adolescent, transgender and LGB-identified patients following
the lecture series. Additionally, respondents indicated greater comfort discussing elective termination of pregnancy, sexual
violence, contraception, medical transitioning and HIV pre-exposure prophylaxis with patients, as well as with identifying
female genital cutting on physical exam.
Since the program’s initial launch, the scope and breadth of the curriculum has grown. In fact, the COVID-19 pandemic
created the unanticipated benefit of moving the previously in-person seminar series to an online platform, which has made
the program more accessible to a larger student audience. Data from this program has already been presented to the SOM
Curriculum Committee and informed the expansion of gender and sexual health topics across the curriculum.
“Our findings demonstrate that a student-initiated lecture series can promote meaningful curriculum change and add value
to the medical student experience. In this case, students were able to demonstrate that seminar participants had significantly
greater comfort in core knowledge domains around sexual health. Our hope is that this program will allow these future
health care professionals to provide more informed and comprehensive patient care for diverse patient populations,” said Dr.
Koestler.

11th Annual Paul K. Woolf, M.D., Pediatric Trainee Research Day Held
The SOM Department of Pediatrics, Boston Children’s Health Physicians and the Children’s Health
and Research Foundation Inc., co-hosted the 11th Annual Paul K. Woolf, M.D., Pediatric Trainee
Research Day on May 19. The event highlighted new and innovative biomedical research in
pediatrics and fostered academic discussions. Four abstracts were selected for oral presentation
and received awards in clinical, translational and basic research categories.

Paul Woolf, M.D.

Chaired by Mitchell S. Cairo, M.D., professor of pediatrics, medicine, pathology, microbiology and
immunology and of cell biology and anatomy, and chief of the Division of Pediatric Hematology,
Oncology and Stem Cell Transplantation, the event honors the memory of the late Paul K. Woolf,
M.D., SOM senior associate dean for Westchester Medical Center (WMC) and associate professor
of pediatrics, who passed away in 2010 at the age of 59. Dr. Woolf was instrumental in developing
the pediatric cardiovascular program at NYMC and the Maria Fareri Children’s Hospital at WMC.
View list of award winners.

Faculty and Student Publications & Accolades
Michael Goligorsky, M.D., the Alvin I. Goodman, M.D., Chair of Nephrology and professor of medicine, pharmacology and
of physiology, has published the second edition of his book, Regenerative Nephrology, which features subjects as diverse
as age and gender influencing regenerative processes; mechanisms and pathways of premature cell senescence affecting
kidney regeneration; and novel mechanistic and engineering efforts to recreate functional kidney or its component parts.
Tolga Sursal, M.D., neurosurgery resident, received the Charlie Kuntz Scholar Award from the Joint Section on Disorders of
the Spine and Peripheral Nerves of the Congress of Neurological Surgeons for his abstract “Involvement of mTOR pathway
modulates autophagy and immune response in recovery from spinal cord injury.”
George W. Contreras, M.E.P., M.P.H., M.S., CEM, FAcEM, assistant director of the Center for Disaster Medicine, assistant
professor in the Institute of Public Health of the School of Health Science and Practice and assistant director of the Advanced
Certificate in Emergency Management Program; SOM students Brigitte Burcescu, Class of 2023; Tiffany Dang, Class of
2022; Jeanette Freeman, Class of 2022; Nathan Gilbreth, Class of 2022; Juliet Jacobson, Class of 2022; and Keerthana
Jayaseelan, Class of 2023; along with David S. Markenson, M.D., M.B.A., director of the Center for Disaster Medicine,
published “Drawing Parallels Among Past Public Health Crises and COVID-19” in Disaster Medicine and Public Health
Preparedness.
Jose Dominguez, M.D., neurosurgery resident; Boyi Li, M.D. ’21; Eric Feldstein, M.D. ’21; John Wainwright, M.D.,
instructor of neurosurgery; Donna Koo, M.D. ’20; Bhawnett Chadha, M.D. ’20; Akshitha Yarrabothula, M.D. ’20; Naina
Rao, M.D. ’21; Anusha Adkoli, M.D. ’21; Ivan Miller, M.D., assistant professor of clinical medicine; Chirag Gandhi, M.D.,
chair of the Department of Neurosurgery and professor of neurosurgery, neurology and of radiology; Fawaz Al-Mufti,
M.D., assistant professor of neurology, neurosurgery and of radiology; and Justin Santarelli, M.D., assistant professor of
neurosurgery, co-authored “Spinal Epidural Abscess Patients Have Higher Modified Frailty Indices than Back Pain Patients on
Emergency Room Presentation: A Single-Center Retrospective Case-Control Study” in World Neurosurgery.
Ilan Fleisher, SOM Class of 2024, published “HIV testing in patients who are HCV positive: Compliance with CDC guidelines
in a large healthcare system” in PLOS ONE.
Daniel Greenberg, M.D., internal medicine resident; Christopher Nabors, M.D., Ph.D., assistant professor of medicine;
Dipak Chandy, M.D., professor of medicine and of neurology; and Abhay Dhand, M.D., associate professor of medicine,
co-authored “Pneumothorax and pneumomediastinum in patients hospitalized with coronavirus disease 2019 (COVID-19)” in
Heart & Lung.
Sara Heide, SOM Class of 2023, published “Autonomy, identity and health: defining quality of life in older age” in the Journal
of Medical Ethics.
Rifat Latifi, M.D., Felicien M. Steichen, M.D., Professor and Chair of Surgery, published “Do young patients with high clinical
suspicion of appendicitis really need cross sectional imaging? Proceedings from a highly controversial debate among the
experts’ panel of 2020 WSES Jerusalem guidelines” in the Journal of Trauma and Acute Care Surgery.
Dionysios Liveris, Ph.D., assistant professor of pathology, microbiology and immunology; Maria Aguero-Rosenfeld, M.D.,
adjunct professor of pathology, microbiology and immunology; Gary Wormser, M.D., professor of medicine, pharmacology
and of pathology, microbiology and immunology; and Ira Schwartz, Ph.D., professor emeritus of pathology, microbiology and
immunology, co-authored “A new genetic approach to distinguish strains of Anaplasma phagocytophilum that appear not to
cause human disease” in Ticks and Tick-Borne Diseases.
Alexander Mittnacht, M.D., clinical professor of anesthesiology, published “New-onset intra-operative hyperthermia in a large
surgical patient population a retrospective observational study” in the European Journal of Anesthesiology.
Jerry L. Nadler, M.D., dean of the SOM and professor of medicine and of pharmacology, published “Regulation of Tissue
Inflammation by 12-Lipoxygenases” in Biomolecules.
William Ross, Ph.D., professor of physiology, published “Mechanism of ArcLight derived GEVIs involves electrostatic
interactions that can affect proton wires” in Biophysical Journal.
Esther Sabban, Ph.D., professor of biochemistry and molecular biology, published “Systematic Review and Methodological
Considerations for the Use of Single Prolonged Stress and Fear Extinction Retention in Rodents” in Frontiers in Behavioral
Neuroscience.
Stephen J. Seligman, M.D., research professor of pathology, microbiology and immunology, published “Auto-antibodies to
type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine” in the Journal of Experimental Medicine.
Changhong Yin, M.D., M.S., research assistant professor of pathology, microbiology and immunology; Weihua Huang,
Ph.D., associate professor of pathology, microbiology and immunology; and Sangmi Chung, Ph.D., associate professor of
cell biology and anatomy, neurology and of psychiatry and behavioral sciences, published “Migratory cortical interneuronspecific transcriptome abnormalities in schizophrenia” in the Journal of Psychiatric Research.
View full list of recent Faculty Publications.
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